Welcome to the Schizophrenia Resource Centre

Welcome, this website is intended for healthcare professionals in EMEA with an interest in the treatment of schizophrenia. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Celso Arango Discusses a New Meta-analysis Presented at ECNP, which Indicates Anti-inflammatory Medicines Potentially Improve the Efficacy of Existing Treatments.

Dr Arango discusses a Meta-analysis study which shows that anti-inflammatory drugs can potentially benefit patients with schizophrenia, in combination with antipsychotics. He suggests that the increace in inflammatory markers are related to the loss in grey matter, which in turn is related to a worse prognosis.

While this is an interesting and potentially important area of research, it is still in its relative infancy, and more studies are needed to determine efficacy and safety before any of the these interventions can be considered for routine clinical practice. -Robin Emsley